А. N. Slatetskaya

ORCID: 0000-0003-0815-9051
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mitochondrial Function and Pathology
  • Biochemical and Molecular Research
  • Metabolism and Genetic Disorders
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • COVID-19 and healthcare impacts

Russian Children's Clinical Hospital
2021-2024

Ministry of Health of the Russian Federation
2021-2024

Pirogov Russian National Research Medical University
2024

The coronavirus infection is a pressing issue in modern healthcare, yet the characteristics of SARS-CoV-2 course children with comorbidities remain insufficiently studied. aim this study was to evaluate clinical form, severity, and duration virus shedding pediatric patients somatic diseases, depending on comorbid pathology. Materials Methods. A comprehensive single-center retrospective conducted, analyzing 314 medical records hospitalized infectious diseases department Russian Children’s...

10.22627/2072-8107-2024-23-4-22-28 article EN cc-by CHILDREN INFECTIONS 2024-11-16

Background. Glutaric aciduria type 1 is an autosomal recessive disease caused by mutations in the GCDH gene, which encodes enzyme glutaryl‑CoA dehydrogenase. Metabolic crisis glutaric acute life‑threatening condition that requires careful diagnosis with a number of other conditions and immediate initiation pathogenetic therapy. Materials methods. Clinical manifestations, neuroimaging characteristics were studied 46 patients diagnosed confirmed biochemical molecular genetic Methods: gas...

10.17650/2222-8721-2021-11-2-61-79 article EN cc-by Neuromuscular Diseases 2021-09-13

Treatment of many the diseases in panel expanded newborn screening includes dietary therapy. Glutaric aciduria type 1 (GA1) is a hereditary disorder caused by mutations gene GCDH , encoding glutaryl‑CoA dehydrogenase, an enzyme amino acid metabolic pathways. The decreased activity leads to accumulation neuro‑ toxic metabolites. recommended treatment approaches for GA1 are prescription specialized nutrition products, levocarnitine, and symptomatic management. In 2021, clinical guidelines this...

10.17650/2222-8721-2021-11-4-12-25 article EN cc-by Neuromuscular Diseases 2021-12-29
Coming Soon ...